Laura Bobolts, PharmD, BCOP, discusses key cost drivers impacting treatments for upper GI and esophageal cancers. Laura Bobolts, PharmD, BCOP: There are 3 main cost drivers I typically think about ...
A panel of experts review the key drivers contributing to the economic impact of inflammatory diseases in the United States. Ryan Haumschild, PharmD, MS, MBA: One thing you talked about was what’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results